Observations made in a controlled double-blind investigation of two non-halogenated topical steroids, hydrocortisone-17-butyrate (HCB) and budesonide in thirty-six patients with psoriasis revealed a clear difference in therapeutic effect between the two ointments, indicating that they belong to different groups of topical steroids according to a classification accepted in the Nordic countries. Budesonide had a good therapeutic effect in all the patients studied, while, as a rule, HCB was clearly less effective.
Get full access to this article
View all access options for this article.
References
1.
AgrupGLassusALidénI SOsmundsenP ERajkaGSøndergaardJ (1978) Classification of Modern Corticosteroid Preparations (in Swedish). Läkartidningen, 75, 19, 1924.
BleekerJEdelandBEilardUGisslénHHersleKKonstman-MeierC HKuokkanenKLarssonRLassosLNordinPNörholmASvenssonLThyboHUnnaP JWikströmK (1980) Long-term multicentre clinical investigation of budesonide 0.025% ointment in psoriasis. In: ‘Abstracts’ the 22nd Nordic Conference on Dermatology, Helsinki. Editors: Mustakallio K and Förström L. p 178.
4.
FredrikssonTSaldeLA double-blind trial of budesonide and betamethasone-17, 21-dipropionate in psoriasis. (In manuscript).
5.
KeczkesKFrain-BellWHoneymanA LSpruntG (1967) The effect on adrenal function of treatment of eczema and psoriasis with triamcinolone acetonide. British Journal of Dermatology79, 475.
6.
LassusASaldeLA double-blind comparison of two topical steroids in psoriasis and eczemas: Budesonide 0.025% ointment and betamethasone-17-valerate 0.1% ointment. (In manuscript).
7.
MayPSteinE JRyterR JGirshF SMichelBLevyR P (1976) Clashing syndrome from percutaneous absorption of triamcinolone cream. Archives of Internal Medicine (Chicago)136, 612.
8.
RyrfeldtÅAnderssonPEdsbäckerS (1980) Liver and skin biotransformation of glucocorticosteroids in hairless mouse, rat and man. In: ‘Abstracts’ the 22nd Nordic Conference on Dermatology, Helsinki. p 181.
9.
SneddonI B (1973) A trial of hydrocortisone butyrate in the treatment of rosacea and perioral dermatitis. British Journal of Dermatology89, 505.
10.
SneddonI B (1980) Perioral dermatitis. British Journal of Dermatology102, 239.
11.
TaylorK SMalkinsonF DGakC (1965) Complications of therapy – pituitary-adrenal function following topical triamcinolone acetonide and occlusion. Archives of Dermatology (Chicago)92, 174.
12.
ThalénABrattsandR (1979) Synthesis and anti-inflammatory properties of budesonide, a new non-halogenated glucocorticoid. Arzneimittel Forschung (Drug Research), 29, (II), 1687.
13.
WilsonL (1976) The clinical assessment of topical corticosteroid activity. British Journal of Dermatology94, suppl. 12, 33.
14.
YasudaT (1974) Systemic effects of the topical corticosteroid hydrocortisone-17-butyrate. Skin Research16, 106.
